Oxana Denisova receives 30 000 grant from Aamu foundation
Oxana Denisova receives 30 000 grant from Aamu foundation for her research on ‘PP2A in medulloblastoma therapy resistance: novel opportunities for targeted therapeutics.’
– My current research interest belongs to a field of brain cancer resistance and anticancer therapy development, particularly I focus on a role of protein phosphatase 2A (PP2A) and its inhibitor proteins in glioblastoma and pediatric medulloblastoma. I recently demonstrated that combination of PP2A reactivation and multi-kinase inhibition results in profound synergistic cell killing of adult glioblastoma and medulloblastoma cells, Oxana tells.
Recent Posts
- New computational tool helps scientists interpret complex single-cell data Researchers from Laura Elo’s group, have developed a new computational method to interpret complex single-cell Read moreNovember 17, 2025
- Carlos Rogério Figueiredo received the Young Investigator Award Carlos Rogério Figueiredo has received the Young Investigator Award from the Scandinavian Society for Immunology. Read moreNovember 4, 2025
- Participate to Open Hardware Workshop, sign up now! Access to research hardware remains a global challenge and it impacts also researchers in high-income Read moreNovember 3, 2025
- The Academy of Finland granted Johanna Ivaska €2,400,000 in funding for an Academy Professor position The Academy of Finland granted our Group Leader, Professor Johanna Ivaska €2,400,000 in funding for Read moreOctober 30, 2025
- Guillaume Jacquemet and Cecilia Sahlgren receive funding for the Research Council of Finland Centre of Excellence in Immune-Endothelial Interactions (IMMENs) Associate Professor Guillaume Jacquemet, our Group Leader, and Professor Cecilia Sahlgren, our affiliated Group Leader, Read moreOctober 30, 2025
- Registration to AI2Med imaging event is now open! Registration for AI2Med Turku 2025 is open! The event is organized by the Turku PET Read moreOctober 21, 2025